This data strongly indicates that certain factors released from the implanted hADSCs acted through paracrine mechanism and inhibited the expression of TGF-β1 which in turn resulted in decreased activation hepatic stellate cells subsequent attenuation of liver fibrosis and cirrhosis. The gene discussed is TGFB1; the disease is Cirrhosis.